blood test Articles
-
Our innovative technology becomes available for patients
Following a successful fundraising in Q4 2016, METAFORA achieves an important milestone by announcing, in partnership with CERBA Healthcare, the availability of the METAglut1 blood test to diagnose the GLUT1 deficiency syndrome (GLUT1 DS). Through METAglut1, our disruptive technology becomes available, for the first time, to patients. De Vivo’s disease (the other name of GLUT1 DS) is ...
-
Validation of ClarityDX Prostate as a Reflex Test to Refine Prediction of Clinically Significant Prostate Cancer: ClinicalTrials.gov ID: NCT03957252
Summary This study is designed to determine the accuracy of the blood test ClarityDX Prostate to predict the results of prostate biopsies in men who have PSA (Prostate Specific Antigen) greater than 3 and no higher than 10 ...
-
A blood-based test that can detect cancer before its symptoms appear
AMADIX strongly believes that prevention is key to extend people’s life. In cancer, prevention is the best way to reduce the chances of having cancer. PREVECOLl® is an AMADIX’ blood-based test for colorectal cancer detection. Read the full new here ...
By Amadix
-
Case Study B - Liquid Biopsy
X-ZELL is collaborating with Singapore General Hospital (SGH) and the National University Hospital Singapore (NUH) to explore how X-ZELL single-cell diagnostics may aid in the early detection of clinically significant prostate cancer in whole blood. The prospectively blinded, 400-patient multi-centre study officially commenced in 2020 and will lay the foundation for the launch of a commercially ...
By X-Zell Inc.
-
Custom fit helmets – can they help protect against concussions?
It appears that high-contact sports such as hockey and football are becoming much more violent. Although both sports have made efforts to remove unnecessary hits from the game, concussions are inevitable when athletes are as strong and fast as they are today. The only reasonable solution is to improve the safety equipment the players use in hopes of protecting them from a traumatic brain ...
-
Home testing for timing of natural frozen embryo transfer (nFET) procedures; a solution for reducing clinic visits during Covid-19
This study sought to determine whether timing of nFET using home ovulation tests (OT) is a viable alternative to multiple clinic visits. Background Natural Frozen Embryo Transfer (nFET) is an increasingly popular procedure as it avoids early embryonic exposure to an artificially created hormonal environment which may be detrimental to pregnancy outcomes.1,2 nFET requires tracking of hormonal ...
By Clearblue
-
Changes in MRE in HCV patients who achieve SVR
Abstract Almost all patients achieved sustained virological response (SVR) by direct-acting antivirals (DAA) therapy, but it is not clear as to what extent DAA therapy affects changes in liver fibrosis after achieving SVR. In this study, we investigated the changes of liver stiffness by magnetic resonance elastogaraphy (MRE) during DAA therapy. A total of 308 patients were enrolled in the study. ...
-
Bio-tech firm recruiting Yukon men for trial, Prostate cancer group says it could save lives
The Yukon chapter of Ride For Dad says a new blood test developed by an Alberta-based company could save the lives of men at risk of prostate cancer. (iStock/Getty Images) A bio-technology company based in Alberta is testing a new process that could result in fewer Yukon men travelling out of territory for prostate cancer biopsies. Private research company Nanostics Inc. and the University of ...
-
NEW Rtx -BAC Plus 1 and Rtx -BAC Plus 2 Columns
Fast, Definitive Data for Blood Alcohol Testing Optimized column selectivities guarantee resolution of ethanol, internal standards, and frequently encountered interferences. Robust and reproducible column chemistry ensures longer column lifetime and accurate, consistent results. 2 minute analysis time increases lab productivity. New Rtx -BAC Plus 1 and Rtx -BAC Plus 2 columns from Restek ...
-
Nano-Flow Cytometry: A Revolutionary Tool for Biomedical Research
Nano-flow cytometry is a revolutionary technology that has the potential to transform early disease detection and diagnosis. Nano-flow cytometers are able to detect and analyze individual nanoparticles, including extracellular vesicles and viruses, with high sensitivity and accuracy. This makes them ideal for detecting diseases at their earliest stages, when they are most treatable. How does ...
-
Clinical Accuracy of the Embrace No Code Blood Glucose Management System - Case Study
About the Study: A study was performed to demonstrate the accuracy of the Embrace No Code Blood Glucose Management System (Embrace) compared to a clinical laboratory reference method (YSI-2300). Healthcare professionals performed the evaluation with 158 patients either with or without diabetes. Fresh capillary whole blood was tested using the Embrace system. Results were compared to YSI-2300 ...
-
New blood-based CRC test is more than 90% accurate, study says
A study of Universal Diagnostics' blood-based colorectal cancer test found it was more than 90 percent accurate, the company announced June 3. The blood test was found to detect colorectal cancer with 92 percent sensitivity and 97 percent specificity. It also was shown to have 89 percent sensitivity and 97 percent specificity detecting early-stage cancer. The test uses single target sequence ...
-
Serum 14-3-3η A Predictor Of Secondary Sjögren’s Syndrome In SLE
Do you have a patient with Systemic Lupus Erythematosus (SLE) that you suspect may also have Sjögren’s Syndrome (SS)? With shared clinical and serological features, overlapping SS with SLE is a comorbidity that is often challenging to identify to promptly assist clinical management. This may also lead to misdiagnoses of other connective tissue disorders. New data on 14-3-3η (eta) ...
-
Universal Diagnostics Initiates Observational Study in the US to Evaluate Cell Free DNA Blood Test for Adenomas and Colorectal Cancer
SEVILLE, Spain--(BUSINESS WIRE)--Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today that it has started a prospective, multi-center observational study in the US for its investigational advanced adenoma (precursor lesions) and colorectal cancer (CRC) detection blood test. UDX is performing ...
-
Diabetomics Lumella - New Point-of-Care Blood Test Kit for Early Detection of Preeclampsia
Abstract Background: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of synovial joints. Anticitrullinated protein autoantibodies are detected by the CCP test in early disease and predict the development of erosive disease as well as extraarticular manifestations. We recently reported that many RA patients have anti-citrullinated albumin (ACA) ...
-
INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma
Data from 144 tissue samples in the feasibility study demonstrated that SubB2M immunohistochemistry detected melanoma with 91% sensitivity and discriminated between malignant melanoma and benign skin lesions. SubB2M-based immunohistochemistry applications represent a new product opportunity for SubB2M in the $1.9b immunohistochemistry market. INOVIQ Ltd (ASX:IIQ) has successfully completed ...
By INOVIQ Ltd
-
Sight Diagnostics raises $71M Series D for its blood analyzer
Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led its Series C round) and crowd-funding platform OurCrowd. With this, the company has now raised a total of $124 million, though the company declined to ...
-
Nanostics is Developing and Validating a Simple Blood Test to Predict Severity of COVID-19 Disease in SARS-CoV-2 Positive Patients
Edmonton, Alberta - Nanostics Inc., a diagnostic healthcare company that focuses on developing tests to determine a patient's disease risk, announced today plans to develop and validate ClarityDX COVID-19; a simple blood test to predict the severity of COVID-19 disease in patients. Nanostics, in collaboration with the Canadian BioSample Repository (CBSR) at the University of Alberta and Century ...
-
Universal Diagnostics - Case Study
Name: Paola Hurtado Job Title: Laboratory Director Company: Universal Diagnostics, Spain Infinity supplies LC-MS used in early detection Universal Diagnostics is a biomedicine start-up focused on the development of cutting-edge technologies in metabolomics, genetics and bioinformatics, with the mission to develop a blood test for early detection. Based on proprietary technologies and ...
-
Israeli hospital pilots rapid diagnostics of blood cancer with Sight Diagnostics
Israeli-founded firm Sight Diagnostics, the company that uses AI and cutting-edge hardware to deliver rapid, complete blood count results, has signed a new research agreement with Jerusalem’s Shaare Zedek Medical Center to identify the possibility of blood cancer using a combination of images and data collected from Sight’s OLO device and patient clinical information provided by the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you